Literature DB >> 23128466

Central pancreatectomy versus spleen-preserving distal pancreatectomy: a comparative analysis of early and late postoperative outcomes.

Traian Dumitrascu1, Andra Scarlat, Mihnea Ionescu, Irinel Popescu.   

Abstract

BACKGROUND/AIM: The aim of the present study is to compare the postoperative and long-term outcomes of central pancreatectomy (CP) and spleen-preserving distal pancreatectomy (SPDP).
METHODS: Clinical, pathological and long-term data were compared between 22 patients who underwent CP and 25 patients who underwent SPDP (2002-2012).
RESULTS: The median length of resected pancreas was 8.5 cm in the SPDP group and 5 cm in the CP group (p < 0.001). The median estimated blood loss was significantly lower in the CP group (p = 0.019). Morbidity was 50% for CPs and 40% for SPDPs (p = 0.564). The rate of pancreatic fistulae was 36% for CPs and 40% for SPDPs (p = 0.530). The rate of new-onset diabetes was nil in the successful CP group and 16% in the SPDP group (p = 0.111).
CONCLUSION: Morbidity and pancreatic fistula rates are not higher after CP when compared to SPDP. The loss of normal pancreatic tissue is significantly lower for CP, and thus there is potentially better preservation of the pancreatic endocrine functions. CP should be considered only in selected cases when preservation of the pancreas is of utmost importance, especially for lesions situated at the level of the pancreatic neck.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 23128466     DOI: 10.1159/000343927

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  7 in total

1.  Roux-en-Y pancreaticojejunostomy reconstruction after deep enucleation of benign or borderline pancreatic lesions: a single-institution experience.

Authors:  Zhiwen Xiao; Guopei Luo; Zuqiang Liu; Kaizhou Jin; Jin Xu; Chen Liu; Liang Liu; Quanxing Ni; Jiang Long; Xianjun Yu
Journal:  HPB (Oxford)       Date:  2015-11-17       Impact factor: 3.647

Review 2.  Limited surgery for benign tumours of the pancreas: a systematic review.

Authors:  H G Beger; M Siech; B Poch; B Mayer; M H Schoenberg
Journal:  World J Surg       Date:  2015-06       Impact factor: 3.352

3.  Short- and long-term outcomes of laparoscopic organ-sparing resection in pancreatic neuroendocrine tumors: a single-center experience.

Authors:  Javier A Cienfuegos; Joseba Salguero; Jorge M Núñez-Córdoba; Miguel Ruiz-Canela; Alberto Benito; Sira Ocaña; Gabriel Zozaya; Pablo Martí-Cruchaga; Fernando Pardo; José Luis Hernández-Lizoáin; Fernando Rotellar
Journal:  Surg Endosc       Date:  2017-01-26       Impact factor: 4.584

4.  Male gender and increased body mass index independently predicts clinically relevant morbidity after spleen-preserving distal pancreatectomy.

Authors:  Traian Dumitrascu; Mihai Eftimie; Andra Aiordachioae; Cezar Stroescu; Simona Dima; Mihnea Ionescu; Irinel Popescu
Journal:  World J Gastrointest Surg       Date:  2018-11-27

5.  Clinical efficacy of middle pancreatectomy contrasts distal pancreatectomy: a single-institution experience and review of literature.

Authors:  Zhen Tan; Peng Chen; Zheng Dong; Bin Zhou; Wei Dong Guo
Journal:  ANZ J Surg       Date:  2019-03-21       Impact factor: 1.872

6.  Central pancreatectomy: an oncologically safe option to treat metastases of other neoplasms of the mid-portion of the pancreas?

Authors:  Traian Dumitrascu; Andra Scarlat; Mihnea Ionescu; Irinel Popescu
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2017-05-23

7.  Overall Postoperative Morbidity and Pancreatic Fistula Are Relatively Higher after Central Pancreatectomy than Distal Pancreatic Resection: A Systematic Review and Meta-Analysis.

Authors:  Parbatraj Regmi; Qing Yang; Hai-Jie Hu; Fei Liu; Hare Ram Karn; Wen-Jie Ma; Cong-Dun Ran; Fu-Yu Li
Journal:  Biomed Res Int       Date:  2020-02-22       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.